Zobrazeno 1 - 10
of 127
pro vyhledávání: '"R. L. Lins"'
Publikováno v:
Pesquisas E Avanços Em Genética E Biologia Molecular ISBN: 9786599965807
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5ea6ed63c598da77738c24545f1a3ad6
https://doi.org/10.53934/9786585062046-11
https://doi.org/10.53934/9786585062046-11
Autor:
Marie-Paule Emonds, Pierre Zachee, Ronald Daelemans, Marc Boogaerts, Willy Goossens, R L Lins
Publikováno v:
Scopus-Elsevier
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ec5a46aa66013a3f48cfe9653d29ee91
https://doi.org/10.3233/ch-1988-83-422
https://doi.org/10.3233/ch-1988-83-422
Autor:
Juerg Nussberger, R. L. Lins, Roland E. Schmieder, Yanntong Chiang, Alan H. Gradman, Margaret F. Prescott
Publikováno v:
International Journal of Clinical Practice. 61:1461-1468
Summary Background: Aliskiren is the first in a new class of orally effective renin inhibitors for the treatment of hypertension. Methods: In 569 patients with mild-to-moderate hypertension, blood pressure (BP), plasma renin activity (PRA) and plasma
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12ae66ccd0b214a9ba17e30f98231650
https://doi.org/10.1111/j.1742-1241.2007.01473.x
https://doi.org/10.1111/j.1742-1241.2007.01473.x
Autor:
Deutsch Paul J, R. Haesen, Liwen Xi, G. Mistry, Michael Hesney, Jacqueline B. McCrea, Chester J. Kitchen, S. Holland, Scott A. Waldman, R. L. Lins, Howard E. Greenberg, J.D. Rogers, Kimberly L. Birk, A. K. Majumdar, S. X. Li, Robert A. Blum, Donald G. Musson
Publikováno v:
Antimicrobial Agents and Chemotherapy. 46:3506-3511
Ertapenem (INVANZ) is a new once-a-day parenteral β-lactam antimicrobial shown to be effective as a single agent for treatment of various community-acquired and mixed infections. The single- and multiple-dose pharmacokinetics of ertapenem at doses u
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b71db0ef03e455fecc65a3117cff5a2
https://doi.org/10.1128/aac.46.11.3506-3511.2002
https://doi.org/10.1128/aac.46.11.3506-3511.2002
Autor:
A. Van Peer, E. Snoeck, Meindert Danhof, V. Piotrovskij, J. Heykants, R L Lins, P. Jacqmin, A G Dupont, R. Van Gool, Robert Woestenborghs
Publikováno v:
European journal of clinical pharmacology
Vrije Universiteit Brussel
Vrije Universiteit Brussel
Objective: The pharmacokinetics and non-linear red blood cell partitioning of the nucleoside transport inhibitor draflazine were investigated in 19 healthy male and female subjects (age range 22–55 years) after a 15-min i.v. infusion of 1 mg, immed
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2212a82e6550b26a52eb6dc042210953
https://doi.org/10.1007/s002280050337
https://doi.org/10.1007/s002280050337
Autor:
M. M.-L. Janssens, R. L. Lins
Publikováno v:
Journal of International Medical Research. 23:167-174
This randomized, double-blind, double-dummy, parallel-group trial was initiated to evaluate and compare the tolerability of once-daily astemizole-D capsules (10 mg astemizole/240 mg pseudoephedrine) and twice-daily loratadine-D tablets (5 mg loratadi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f523dae13b4c03742288eb869565062e
https://doi.org/10.1177/030006059502300303
https://doi.org/10.1177/030006059502300303
Publikováno v:
Drug Investigation. 2:214-218
In a double-blind placebo-controlled randomised crossover study, the antihypertensive activity and tolerability of 2 combination preparations, containing a diuretic and a potassium-sparing agent, were evaluated in the treatment of essential hypertens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::0edbf8dc1839a837b5ac1d3367ee04cc
https://doi.org/10.1007/bf03259199
https://doi.org/10.1007/bf03259199
Publikováno v:
International journal of clinical practice. 61(9)
Aliskiren is the first in a new class of orally effective renin inhibitors for the treatment of hypertension.In 569 patients with mild-to-moderate hypertension, blood pressure (BP), plasma renin activity (PRA) and plasma renin concentration (PRC) wer
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::8afb827944792014eb16f283d1b35082
https://pubmed.ncbi.nlm.nih.gov/17686087
https://pubmed.ncbi.nlm.nih.gov/17686087
Publikováno v:
International journal of clinical pharmacology and therapeutics. 45(1)
Objective: Concentrations in saliva, as an alternative to concentrations in blood, can be advantageous for the monitoring of antiepileptic agents. This study assesses the relationship between saliva and plasma concentrations of levetiracetam after ad
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cbedd144d3be030870ff39448a20049
https://pubmed.ncbi.nlm.nih.gov/17256450
https://pubmed.ncbi.nlm.nih.gov/17256450
Autor:
R. L. Lins, M. M. Elseviers, R. Daelemans, P. Arnouts, J.-M. Billiouw, M. Couttenye, E. Gheuens, P. Rogiers, R. Rutsaert, P. Van der Niepen, M. E. De Broe
Publikováno v:
Nephrology Dialysis Transplantation; Sep2004, Vol. 19 Issue 9, p2282-2288, 7p